GB0317869D0 - Improved drug delivery system - Google Patents

Improved drug delivery system

Info

Publication number
GB0317869D0
GB0317869D0 GBGB0317869.6A GB0317869A GB0317869D0 GB 0317869 D0 GB0317869 D0 GB 0317869D0 GB 0317869 A GB0317869 A GB 0317869A GB 0317869 D0 GB0317869 D0 GB 0317869D0
Authority
GB
United Kingdom
Prior art keywords
weight
delivery system
drug delivery
biliquid foam
improved drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0317869.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Disperse Ltd
Original Assignee
Disperse Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Disperse Ltd filed Critical Disperse Ltd
Priority to GBGB0317869.6A priority Critical patent/GB0317869D0/en
Publication of GB0317869D0 publication Critical patent/GB0317869D0/en
Priority to DK04767956.8T priority patent/DK1653923T3/da
Priority to CN2009101468709A priority patent/CN101579311B/zh
Priority to US10/566,209 priority patent/US20060228408A1/en
Priority to ES04767956T priority patent/ES2344898T3/es
Priority to DE602004026879T priority patent/DE602004026879D1/de
Priority to EP04767956A priority patent/EP1653923B1/en
Priority to AT04767956T priority patent/ATE465715T1/de
Priority to CNA2004800223841A priority patent/CN1832727A/zh
Priority to JP2006521672A priority patent/JP4953815B2/ja
Priority to RU2006106173/15A priority patent/RU2353350C2/ru
Priority to PCT/GB2004/003329 priority patent/WO2005011628A2/en
Priority to ZA200600761A priority patent/ZA200600761B/en
Priority to AU2004261053A priority patent/AU2004261053B2/en
Priority to CA2533833A priority patent/CA2533833C/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
GBGB0317869.6A 2003-07-30 2003-07-30 Improved drug delivery system Ceased GB0317869D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB0317869.6A GB0317869D0 (en) 2003-07-30 2003-07-30 Improved drug delivery system
CA2533833A CA2533833C (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam
EP04767956A EP1653923B1 (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam
CNA2004800223841A CN1832727A (zh) 2003-07-30 2004-07-30 改进的药物递送系统
US10/566,209 US20060228408A1 (en) 2003-07-30 2004-07-30 Drug delivery system
ES04767956T ES2344898T3 (es) 2003-07-30 2004-07-30 Sistema de administracion oral que comprende una espuma biliquida.
DE602004026879T DE602004026879D1 (de) 2003-07-30 2004-07-30 Orales abgabesystem mit einem biliquid foam
DK04767956.8T DK1653923T3 (da) 2003-07-30 2004-07-30 Oral afleveringssystem omfattende en bivæsket skum
AT04767956T ATE465715T1 (de) 2003-07-30 2004-07-30 Orales abgabesystem mit einem biliquid foam
CN2009101468709A CN101579311B (zh) 2003-07-30 2004-07-30 改进的药物递送系统
JP2006521672A JP4953815B2 (ja) 2003-07-30 2004-07-30 改良された薬物送達システム
RU2006106173/15A RU2353350C2 (ru) 2003-07-30 2004-07-30 Усовершенствованная система доставки лекарств
PCT/GB2004/003329 WO2005011628A2 (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam
ZA200600761A ZA200600761B (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam
AU2004261053A AU2004261053B2 (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0317869.6A GB0317869D0 (en) 2003-07-30 2003-07-30 Improved drug delivery system

Publications (1)

Publication Number Publication Date
GB0317869D0 true GB0317869D0 (en) 2003-09-03

Family

ID=27799499

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0317869.6A Ceased GB0317869D0 (en) 2003-07-30 2003-07-30 Improved drug delivery system

Country Status (14)

Country Link
US (1) US20060228408A1 (enExample)
EP (1) EP1653923B1 (enExample)
JP (1) JP4953815B2 (enExample)
CN (2) CN1832727A (enExample)
AT (1) ATE465715T1 (enExample)
AU (1) AU2004261053B2 (enExample)
CA (1) CA2533833C (enExample)
DE (1) DE602004026879D1 (enExample)
DK (1) DK1653923T3 (enExample)
ES (1) ES2344898T3 (enExample)
GB (1) GB0317869D0 (enExample)
RU (1) RU2353350C2 (enExample)
WO (1) WO2005011628A2 (enExample)
ZA (1) ZA200600761B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0404403D0 (en) * 2004-02-27 2004-03-31 Disperse Ltd Dispersions
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
GB0712389D0 (en) * 2007-06-26 2007-08-01 Drug Delivery Solutions Ltd A Pharmaceutical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
CN101780037B (zh) * 2010-02-03 2011-11-16 南昌大学 双嘧达莫自乳化给药系统及其制备方法
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
ES2736256T3 (es) 2011-03-14 2019-12-27 Drug Delivery Solutions Ltd Composición oftálmica
EP3178470A1 (en) * 2011-04-11 2017-06-14 Vitux Group AS Oral pharmaceutical dispersion compositions
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) * 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
US4999198A (en) * 1989-03-23 1991-03-12 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Polyaphrons as a drug delivery system
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5840881A (en) * 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
AU721918B2 (en) * 1996-03-08 2000-07-20 Disperse Limited Dispersion comprising an oil-based biliquid foam and an aqueous gel
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
CN1362873A (zh) * 2000-02-22 2002-08-07 彩色通路公司 胶凝的水溶液美容组合物
GB0214793D0 (en) * 2002-06-26 2002-08-07 Disperse Technologies Plc Biliquid foam entrapment

Also Published As

Publication number Publication date
AU2004261053B2 (en) 2011-08-25
ATE465715T1 (de) 2010-05-15
JP2007500181A (ja) 2007-01-11
WO2005011628A3 (en) 2005-05-06
AU2004261053A1 (en) 2005-02-10
JP4953815B2 (ja) 2012-06-13
ZA200600761B (en) 2007-05-30
CA2533833A1 (en) 2005-02-10
CN101579311B (zh) 2013-11-27
EP1653923A2 (en) 2006-05-10
RU2006106173A (ru) 2007-09-10
DE602004026879D1 (de) 2010-06-10
ES2344898T3 (es) 2010-09-09
US20060228408A1 (en) 2006-10-12
CA2533833C (en) 2013-05-28
CN1832727A (zh) 2006-09-13
DK1653923T3 (da) 2010-08-09
CN101579311A (zh) 2009-11-18
EP1653923B1 (en) 2010-04-28
RU2353350C2 (ru) 2009-04-27
WO2005011628A2 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2001085257A3 (en) Opioid antagonist compositions and dosage forms
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
BG105857A (en) Pregelatinized starch in a controlled release formulation
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
AU7315301A (en) Compounds and compositions for delivering active agents
WO2007048219A3 (en) Sustained drug release composition
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
IT1318539B1 (it) Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
EP1790340A3 (en) Combination chemotherapy
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
WO2003045306A3 (en) Phenoxy amine compounds and compositions for delivering active agents
WO2005112633A3 (en) Compounds and compositions for delivering active agents
MY157790A (en) Trazodone composition for once a day administration
WO2008060934A3 (en) Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
WO2008023016A3 (en) Galenic formulations of aliskiren
PL1750862T3 (pl) Kompozycja farmaceutyczna zawierająca irbesartan
WO2002015959A3 (en) Compounds and compositions for delivering active agents
GB0317869D0 (en) Improved drug delivery system
WO2004066983A3 (en) Controlled release of highly soluble agents
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof
JP2007500181A5 (enExample)
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)